Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Determining whether the utilization of Noraxon myoRESEARCH Software gait analysis Evaluation and orthotic gait Correction can reduce diabetic foot ulceration Or subsequent amputation in patients with a history of a diabetic foot ulceration.
The purpose of this study is to identify emerging abnormal structural pathology of the vulnerable re-ulcerative diabetic foot incorporating physical therapy evaluation as well as the Noraxon gait analysis to generate quantitative and qualitative gait data. Once peak foot pressures and gait pathology is identified, gait remedy is fabricated including either a foot orthotic and/or an ankle foot prosthesis. Evaluation of constructed remedy will then be evaluated focusing on gait analysis data to validate decreased plantar foot peak pressures and gait realignment towards the reduction of the diabetic foot re-ulceration and subsequent foot or limb loss.
Not provided
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Noraxon myoRESEARCHâ„¢ Software | Experimental | All participants will be assigned to this group to receive study intervention. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Noraxon myoRESEARCHâ„¢ Software Gait Analysis Evaluation and Orthotic | Device | Physical therapy evaluation (range of motion, strength, mobility, scale). Noraxon based gait assessment on treadmill while barefoot and with instrumented inner soles. Over ground walking assessment (with wireless instrumented inner soles, observational gait analysis while climbing stairs, ramps, curbs). Noraxon gait assessment and walking on treadmill will be video recorded for assessment. Standard measure of functionality and 6 minute walk test will be conducted. Patient will be fitted with corrective orthotics, based on usual care. Physical therapy re-evaluation. Noraxon based gait assessment and foot assessment (any areas of irritation, callus formation, swelling, ulcer formation, and gait mobility irregularities will be monitored and reassessed) throughout the study. |
| Measure | Description | Time Frame |
|---|---|---|
| Number of re-ulceration occurrences | Number of re-ulceration occurrences will be assessed to determine the rate of re-ulceration in patients. | One year |
| Measure | Description | Time Frame |
|---|---|---|
| Number of major proximal amputation occurrences | Number of major proximal amputation occurrences will be counted. | One year |
| Change of peak plantar pressure (n/cm^2) | Assessment will be done at follow up visits. |
Not provided
Inclusion Criteria:
Exclusion Criteria:
Patients who are:
Not provided
Not provided
Not provided
Not provided
| Name | Role | Phone | Extension | |
|---|---|---|---|---|
| Priscilla Frost-Larity | Contact | 4109555165 | pfrostl1@jhmi.edu |
| Name | Affiliation | Role |
|---|---|---|
| Ronald Sherman, DPM, MBA | Johns Hopkins University | Principal Investigator |
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Johns Hopkins Hospital | Recruiting | Baltimore | Maryland | 21287 | United States |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Prospective, Single Center, Non-Randomized, Single treatment group
Not provided
Not provided
Not provided
Not provided
|
| Every 3 months, up to one year |
| Change of length of gait (m) | Assessment will be done at follow up visits. | Every 3 months, up to one year |
| Location of amputation | If any amputation occurs, the location (level of amputation) will be assessed by looking at the stump or from information in patient medical records. Locations include below the knee (transtibial), at the knee (knee disarticulation), above the knee (transfemoral) and at the hip (hip disarticulation). | One year |
| Number of patients who remain in remission | Remission is defined as being ulcer free. | One year |
| Percentage of patients who do not experience re-ulceration after custom orthosis | The percentage of patients who do not experience re-ulceration after custom orthosis. | One year |
| ID | Term |
|---|---|
| D017719 | Diabetic Foot |
| ID | Term |
|---|---|
| D003925 | Diabetic Angiopathies |
| D014652 | Vascular Diseases |
| D002318 | Cardiovascular Diseases |
| D016523 | Foot Ulcer |
| D007871 | Leg Ulcer |
| D012883 | Skin Ulcer |
| D012871 | Skin Diseases |
| D017437 | Skin and Connective Tissue Diseases |
| D048909 | Diabetes Complications |
| D003920 | Diabetes Mellitus |
| D004700 | Endocrine System Diseases |
| D003929 | Diabetic Neuropathies |
Not provided
Not provided
| ID | Term |
|---|---|
| D009989 | Orthotic Devices |
| ID | Term |
|---|---|
| D009983 | Orthopedic Equipment |
| D013523 | Surgical Equipment |
| D004864 | Equipment and Supplies |
Not provided
Not provided